Ipca Laboratories Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Pranay Godha
Chief Executive Officer (CEO)
₹51.0m
Compensación total
| Porcentaje del salario del CEO | 25.9% |
| Permanencia del CEO | 1.2yrs |
| Participación del CEO | 0.7% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 11.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively
Jun 07
Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing
May 24Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It
Jan 15Ipca Laboratories (NSE:IPCALAB) Seems To Use Debt Rather Sparingly
Dec 31
Don't Ignore The Fact That This Insider Just Sold Some Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Dec 16The Case For Ipca Laboratories Limited (NSE:IPCALAB): Could It Be A Nice Addition To Your Dividend Portfolio?
Dec 13This Insider Has Just Sold Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Nov 28Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Nov 25Ipca Laboratories Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 10Is Ipca Laboratories Limited's (NSE:IPCALAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Nov 08Do Insiders Own Lots Of Shares In Ipca Laboratories Limited (NSE:IPCALAB)?
Oct 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹6b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹5b |
| Mar 31 2023 | ₹51m | ₹13m | ₹5b |
| Dec 31 2022 | n/a | n/a | ₹5b |
| Sep 30 2022 | n/a | n/a | ₹6b |
| Jun 30 2022 | n/a | n/a | ₹7b |
| Mar 31 2022 | ₹46m | ₹12m | ₹9b |
| Dec 31 2021 | n/a | n/a | ₹9b |
| Sep 30 2021 | n/a | n/a | ₹10b |
| Jun 30 2021 | n/a | n/a | ₹10b |
| Mar 31 2021 | ₹32m | ₹8m | ₹11b |
| Dec 31 2020 | n/a | n/a | ₹11b |
| Sep 30 2020 | n/a | n/a | ₹10b |
| Jun 30 2020 | n/a | n/a | ₹9b |
| Mar 31 2020 | ₹33m | ₹8m | ₹6b |
| Dec 31 2019 | n/a | n/a | ₹6b |
| Sep 30 2019 | n/a | n/a | ₹6b |
| Jun 30 2019 | n/a | n/a | ₹5b |
| Mar 31 2019 | ₹29m | ₹8m | ₹4b |
| Mar 31 2018 | ₹25m | ₹7m | ₹2b |
Compensación vs. Mercado: La compensación total ($USD611.87K) de Pranay está en línea con el promedio de empresas de tamaño similar en el mercado Indian ($USD539.67K).
Compensación vs. Ingresos: La compensación de Pranay ha sido consistente con los resultados de la empresa en el último año.
CEO
Pranay Godha (52 yo)
1.2yrs
Permanencia
₹50,976,382
Compensación
Mr. Pranay Premchand Godha served as the President of APIs & Generics at Ipca Laboratories Limited and joined it on April 16, 2003. He serves as Non-Executive, Non-Independent Director at Unichem Laborator...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 48.7yrs | ₹112.65m | 2.29% ₹ 6.8b | |
| CEO, MD & Executive Director | 15.6yrs | ₹50.98m | 0.67% ₹ 2.0b | |
| CFO, MD & Executive Director | 29.8yrs | ₹77.54m | 0.017% ₹ 49.1m | |
| Executive Director | 12.8yrs | ₹46.00m | 0.62% ₹ 1.8b | |
| Independent & Non-Executive Director | 9.8yrs | ₹950.00k | sin datos | |
| Additional Independent Director | 1.7yrs | ₹600.00k | sin datos | |
| Lead Independent Director | 5.3yrs | ₹1.40m | 0.00067% ₹ 2.0m | |
| Independent Director | less than a year | sin datos | sin datos |
11.3yrs
Permanencia media
69yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de IPCALAB son experimentados ( 11.1 años antigüedad media).